Carbamazepine - Adverse effects
Research News and Information

Sunday, November 22, 2009

Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal--a RCT.

30 Aug 2009 INTRODUCTION: Oxcarbazepine (OXC), a derivative of Carbamazepine (CBZ), may represent a solution to metabolic and side effects of CBZ treatment due to the fact that renal excretion is its major route of elimination. The goal of the study is to ... Read more...

The use of antiepileptic drugs in pediatric brain tumor patients.

30 Aug 2009 Antiepileptic drugs are frequently used in children with brain tumors. This retrospective study reviewed chronic use of antiepileptic drugs in children with brain tumors at two children's hospitals between 2000 and 2007. Antiepileptic drugs were ... Read more...

The effect of oxcarbazepine on bone metabolism.

30 Aug 2009 OBJECTIVE: Long term use of several antiepileptic drugs is known to cause alteration in bone metabolism. Therefore, we investigated the effect of new antiepileptic drug, oxcarbazepine, on bone metabolism. METHODS: Twenty eight patients who were on ... Read more...

Latest indexed articles for 'Carbamazepine - Adverse effects'

These are the very latest articles for this heading:

• Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal--a RCT. 30 Aug 2009
• The use of antiepileptic drugs in pediatric brain tumor patients. 30 Aug 2009
• The effect of oxcarbazepine on bone metabolism. 30 Aug 2009
• Pregnancy treatment guidelines: throwing the baby out with the bath water. 30 Aug 2009
• Carbamazepine-induced hyperammonemia. 13 Aug 2009
• Drug-induced hypersensitivity syndrome with superficial granulomatous dermatitis--a novel finding. 30 Jul 2009
• Prospective study on long-term treatment with oxcarbazepine in pediatric epilepsy. 12 Jul 2009
• Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosing. 29 Jun 2009
• Heparin-induced thrombocytopenia in a nonthrombocytopenic patient with toxic epidermal necrolysis causing fatal outcome: is HIT still a HIT? 29 Jun 2009
• Effectiveness of the first antiepileptic drug in the treatment of pediatric epilepsy. 29 Jun 2009
• [Opioid effectiveness for neuropathic pain in a patient with glossopharyngeal neuralgia] 30 May 2009
• [Severe hyponatremia by oxcarbazepine in an elderly] 30 May 2009
• The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. 4 May 2009
• Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study. 29 Apr 2009
• Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. 14 Apr 2009
• Drug interaction between tacrolimus and carbamazepine in a Japanese heart transplant recipient: a case report. 30 Mar 2009
• Genetic basis for idiosyncratic reactions to antiepileptic drugs. 30 Mar 2009
• Correspondence on "Lipid profile, apolipoproteins A and B in children with epilepsy''. 30 Mar 2009
• [Reversible posterior leukoencephalopathy syndrome associated with carbamazepine-induced hypertension] 30 Mar 2009
• eComment: Plasmapheresis for near-fatal heparin-induced thrombocytopenia. 30 Mar 2009

See a longer list of these articles.

Technical information about 'Carbamazepine'

Definition: An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.

Chemical name: 5H-Dibenz(b,f)azepine-5-carboxamide

Registry Number: 298-46-4

Descriptor UI: D002220

Alternative terms: Carbamazepine; Neurotol; Tegretol; Amizepine; Carbamazepine Acetate; Acetate, Carbamazepine; Epitol; Carbamazepine Hydrochloride; Hydrochloride, Carbamazepine; Carbamazepine L-Tartrate (4:1); Carbamazepine Phosphate; Phosphate, Carbamazepine; Carbamazepine Sulfate (2:1); Carbazepin; Finlepsin; Carbamazepine Dihydrate; Dihydrate, Carbamazepine;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Analgesics, Non-Narcotic; Anticonvulsants; Antimanic Agents;

Tree Number: D03.494.240.127;

History Note: 72(68)